Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AbbVie halts phase III TAHOE trial of Rova-T for SCLC

pharmaceutical-technologyDecember 10, 2018

Tag: AbbVie , TAHOE trial , SCLC , Rova-T

PharmaSources Customer Service